Mostrar el registro sencillo del ítem
The multikinase inhibitor EC-70124 synergistically increased the antitumor activity of doxorubicin in sarcomas
dc.contributor.author | Estupiñán Sánchez, Óscar Rafael | |
dc.contributor.author | Santos, L. | |
dc.contributor.author | Rodríguez, A. | |
dc.contributor.author | Tornin Cavielles, Juan | |
dc.contributor.author | Allonca Campa, Eva | |
dc.contributor.author | Fernández García, María Teresa | |
dc.contributor.author | Braña Vigil, Alejandro Francisco | |
dc.contributor.author | Astudillo González, María Aurora | |
dc.contributor.author | Tirados Menéndez, Sofía | |
dc.contributor.author | Rodríguez González, René | |
dc.date.accessioned | 2019-08-21T07:33:16Z | |
dc.date.available | 2019-08-21T07:33:16Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | International Journal of Cancer, 145(1), p. 254-266 (2019); doi:10.1002/ijc.32081 | |
dc.identifier.issn | 0020-7136 | |
dc.identifier.uri | http://hdl.handle.net/10651/51883 | |
dc.description.sponsorship | This work was supported by the Agencia Estatal de Investigación (AEI)[MICINN/Fondo Europeo de Desarrollo Regional (FEDER) (RTC2016-4603-1 to EntreChem SL and SAF-2016-75286-R toR.R.), ISC III/FEDER [Miguel Servet Program] (CPII16/00049 to R.R.), Sara Borrell Program (CD16/00103 toS-T.M.) and Consorcio CIBERONC (CB16/12/00390)] and the Plan de Ciencia Tecnología e Innovación del Principado de Asturias (GRUPIN14-003). We want to particularly acknowledge for its collaboration, the Principado de Asturias BioBank (PT17/0015/0023),financed jointly by Servicio de Salud del Principado de Asturias, Instituto de Salud Carlos III and Fundación Bancaria Cajastur and integrated in the Spanish National Biobanks Network. | |
dc.description.statementofresponsibility | Estupiñan, O., Santos, L., Rodriguez, A., Fernandez-Nevado, L., Costales, P., Perez-Escuredo, J., Hermosilla, M.A., Oro, P., Rey, V., Tornin, J., Allonca, E., Fernandez-Garcia, M.T., Alvarez-Fernandez, C., Braña, A., Astudillo, A., Menendez, S.T., Moris, F., Rodriguez, R. | |
dc.format.extent | p. 254-266 | |
dc.language.iso | eng | |
dc.relation.ispartof | International Journal of Cancer | |
dc.rights | © 2018 UICC | |
dc.rights | CC Reconocimiento - No Comercial - Sin Obra Derivada 4.0 Internacional | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.source | Scopus | |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060011052&doi=10.1002%2fijc.32081&partnerID=40&md5=204a968313b9d005db860ada7b6d708d | |
dc.title | The multikinase inhibitor EC-70124 synergistically increased the antitumor activity of doxorubicin in sarcomas | |
dc.type | journal article | |
dc.identifier.doi | 10.1002/ijc.32081 | |
dc.relation.projectID | RTC2016-4603-1 | |
dc.relation.projectID | AF-2016-75286-R | |
dc.relation.projectID | GRUPIN14-003 | |
dc.relation.projectID | PT17/0015/0023 | |
dc.relation.publisherversion | http://dx.doi.org/10.1002/ijc.32081 | |
dc.rights.accessRights | open access | |
dc.type.hasVersion | AM |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Artículos [36140]
-
Biología Funcional [754]
-
Investigaciones y Documentos OpenAIRE [7870]
Publicaciones resultado de proyectos financiados con fondos públicos